PREGNANCY AND CHILDBIRTH IN A PATIENT WITH SPINAL MUSCULAR ATROPFY (CLINICAL CASE)
Main Article Content
Abstract
Spinal muscle atrophy (SMA) is a group of diseases inherited by an autosomal recessive type and characterized by degeneration of cells of the anterior horns of the spinal cord. The disease leads to progressive atrophy and weakening of skeletal muscles. There are spinal muscular atrophies with a frequency of 1 : 25000 people, the frequency of heterozygous carriage is 1 in 40-60 people.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Amold WD, Kassar D, Kissel JT. Spinal muscular atrophy diagnosis and management in a new therapeutic era. Muscle Nerve. 2015; 51(2): 157-167
Darras BT. Spinal muscular atrophies. Pediatr. Clin. North Am. 2015; 62(3): 743-766
Faravelli I, Nizzardo M, Comi GP, Corti S. Spinal muscular atrophy – recept therapeutic advances for an old challenge. Nat. Rev. Neurol. 2015; 11(6): 351-359
Astrea G, Brisca G, Fiorillo C et al. Muscle MRI in TRPV4-related congenital distal SMA. Neurology. 2012; 78(5): 364-365. DOI: 10.1212/WNL.0b013e318245295a
Neveling K, Martinez-Carrera LA, Hölker I, Heister A, Verrips A, Hosseini-Barkooie SM et al. Mutations in BICD2, wich encodes a Goldin and important motor adaptor, caust congenital autosomal-dominant spinal muscular atrophy. Am J Hum Genet. 2013; 92(6): 946-954. DOI: 10.1016/j.ajhg.2013.04.011
Scoto M, Rossor AM, Harms MB, Cirak S, Calissano M, Robb S et al. Novel mutations expand the clinicalspec-trumof DYNC1H1-associatedspinal muscular atrophy. Neurology. 2015; 84(7): 668-679. DOI: 10.1212/WNL.0000000000001269
Tsurusaki Y, Saitoh S, Tomizawa K, Sudo A, Asahina N, Shiraishi H et al. A DYNC1H1 mutation causes a dominant spinal muscular atrophy with lower extremity predominance. Neurogenetics. 2012; 13(4): 327-332. DOI: 10.1007/ s10048-012-0337-6
Willemsen MH, Vissers LE, Willemsen MA, van Bon BWM, Kroes T, Ligt J et al. Mutations in DYNC1H1 cause severe intellectual disability with neuronal migration defects. J Med Genet. 2012; 49(3): 179-183. DOI: 10.1136/jmed-genet-2011-100542
Poirier K, Lebrun N, Broix L et al. Mutations in TUBG1, DYNC1H1, KIF5C and KIF2A cause malformations of cortical development and microcephaly. Nat Genet. 2013; 45(6): 10.1038/ng.2613. DOI: 0.1038/ng.2613
Beecroft SJ, McLean CA, Delatycki MB, Koshy K, Yiu E, Haliloglu G et al. Expanding the phenotypic spectrum associated with mutations of DYNC1H1. Neuromuscul Disord. 2017; 27(7): 607-615. DOI: 10.1016/j.nmd.2017.04.011
Chan S, Ip J, Mak C et al. Lower extremity predominance spinal muscular atrophy by DYNC1H1 mutation. Conference: 29th Annual Scientific Meeting of the Hong Kong Neurological Society. Hong Kong, 2016
Harms MB, Allred P, Gardner R, Filho JAF, Florence J, Pestronk A et al. Dominant spinal muscular atrophy with lower extremity predominance: linkage to 14q32. Neurology. 2010; 75(6): 539-546. DOI: 10.1212/WNL.0b013e3181ec800c
Schiavo G, Greensmith L, Hafezparast M, Fisher EM. Cytoplasmic dynein heavy chain: the servant of many masters. Trends Neurosci. 2013; 36(11): 641-651. DOI: 10.1016/j.tins.2013.08.001
Shibelgut NM, Zakharov IS, Moses VG. Clinical and biochemical manifestations of undifferentiated forms of connective tissue dysplasia in pregnant women with varicose veins of the small pelvis. Saratov Journal of Medical Scientific Researc. 2010; 1: 56-60. Russian (Шибельгут Н.М., Захаров И.С., Мозес В.Г. Клинико-биохимические проявления недифференцированных форм дисплазии соединительной ткани у беременных с варикозной болезнью вен малого таза //Саратовский научно-медицинский журнал. 2010. Т. 6, № 1. С. 056-060)